Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000031.pdf 0001968202-23-000031.xls
Aug 24, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001732.pdf
Aug 23, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000022.pdf 0001968202-23-000022.xls
Aug 23, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000023.pdf 0001968202-23-000023.xls
Aug 23, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001731.pdf
Aug 23, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-23-000321.pdf
Aug 22, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-23-000315.pdf
Aug 21, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001000275-23-000037.pdf
Aug 18, 2023	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	View HTML 0001104659-23-093555.pdf 0001104659-23-093555.xls
Aug 11, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000077.pdf 0001883850-23-000077.xls

Data provided by Kaleidoscope.

Investors & Media